跳至主要内容
临床试验/JPRN-UMIN000035829
JPRN-UMIN000035829招募中未知

The effect of intravitreal injection of ranibizumab before direct photocoagulation in the treatment of focal diabetic macular edema - Ranibizumab treatment with lasers for focal DME

niversity of Fukui, Ophthalmology0 个研究点目标入组 50 人开始时间: 2019年2月13日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • A history of any intraocular surgery in the study eye within the previous 90 days It is considered difficult to improve visual acuity due to morphological changes Glaucoma with poor IOP control, a history of glaucoma filtering surgery, or scheduled filtering surgery in the study eye IOP of the study eye: more than 25 mmHg Myopia of -8D or greater Optic media in which it is difficult to obtain fundus photographs or OCT images Severe systemic infections at baseline Systemic anticoagulation therapy within 180 Poorly controlled diabetes mellitus Poorly controlled hypertension A history of cerebrovascular accident and/or myocardial infarction within 180 days Patients on dialysis and patients with renal failure requiring dialysis

研究者

发起方
niversity of Fukui, Ophthalmology

相似试验

进行中(未招募)
不适用
Comparison of the effect of intravitreal ranibizumab injections compared to macular grid-pattern laser therapy for the symptomatic treatment of diabetic macular edema (a randomized, controlled, phase III trial)Randomizált, kontrollált, III. fázisú klinikai vizsgálat az intravitreális ranibizumab injekció és a makula „grid pattern” (rács mintázatú) lézerkezelés hatásának összehasonlítására a diabéteszes makula ödéma tüneti kezelésében.Diabetic Macular EdemaMedDRA version: 9.1Level: LLTClassification code 10057934Term: Diabetic macular edema
EUCTR2008-007232-18-HUniversity of Szeged, Medical and Pharmaceutical Center, Department of Ophthalmology50
已完成
不适用
The effect of intravitreal injection of bevacizumab after vitrectomy for proliferative diabetic retinopathyproliferative diabetic retinopathy
JPRN-UMIN000009801Tokyo medical university20
已完成
4 期
A multicentre,open-label,prospective,observational study to evaluate effectiveness and safety of repeated intravitreal injections of Lucentis® in patients with wet age-related macular degeneration over a 12-month observational period in a real-world setting
CTRI/2013/08/003933ovartis India Limited3,000
招募中
不适用
The effect of intravitreal ranibizumab on systemic hypertension in age-related macular degeneration patients with hypertension.age-related macular degeneration
JPRN-UMIN000013240Institute of Health Biosciences, The University of Tokushima Graduate School80
已完成
不适用
Comparison of intravitreal ranibizumab injection with or without tissue plasminogen activator in the treatment of type 2 choroidal neovascularizationeovascular age-related macular degeneration
JPRN-UMIN000017081Department of Ophthalmology and Visual Science Nagoya City University Graduate School of Medical Sciences20